11 of 132 unique stocks in common · Jaccard: 8.3%
A weighted portfolio overlap of 9.61% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹9.61 is allocated to the exact same companies at the same relative proportions. The schemes share 11 common holdings.
The largest overlapping asset in their portfolios is Gland Pharma, which commands a weight of 2.20% in DSP Multicap Fund and 1.72% in HDFC Manufacturing Fund. Holding both schemes increases your concentration in Gland Pharma rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in DSP | in HDFC |
|---|---|---|
| Gland PharmaPharmaceuticals & Biotechnology | 2.20% | 1.72% |
| Mahindra & MahindraAutomobiles | 1.56% | 3.59% |
| SiemensElectrical Equipment | 1.26% | 1.25% |
| Bharat Petroleum CorporationPetroleum Products | 1.13% | 1.64% |
| Jubilant IngreviaChemicals & Petrochemicals | 1.01% | 0.75% |
| Hindustan AeronauticsAerospace & Defense | 0.71% | 2.50% |
| Schaeffler IndiaAuto Components | 1.78% | 0.70% |
| Archean Chemical IndustriesChemicals & Petrochemicals | 1.55% | 0.69% |
| Crompton Greaves Consumer ElectricalsConsumer Durables | 0.77% | 0.54% |
| Cohance LifesciencesPharmaceuticals & Biotechnology | 1.06% | 0.38% |
| JNK IndiaIndustrial Manufacturing | 0.85% | 0.18% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.